Pattern-based patient selection associated with positive clinical trial results

This new article publication from Acta Pharmaceutica Sinica B discusses the association between using traditional Chinese medicine patterns to select participants and statistically significant primary outcomes in randomized placebo-controlled trials of Chinese herbal formulas.

Traditional Chinese medicine (TCM) pattern differentiation groups patients with the same disease according to their symptoms and signs to guide treatment selection. Whether using these patterns in trial eligibility is associated with reported outcomes remains unclear. The authors of this article analyzed 378 published randomized placebo-controlled trials of Chinese herbal formulas, identified through eight databases and published between January 1, 2020, and October 21, 2025. The trials included 92,691 participants in their primary outcome analyses. Of these trials, 197 (52.1%) used TCM patterns as an inclusion criterion. Statistically significant primary outcomes were reported in 94.9% of trials using patterns, compared with 75.7% of those that did not.

After adjustment for four prespecified trial characteristics, pattern-based inclusion was associated with a 14% higher likelihood of reporting statistically significant primary outcomes (adjusted risk ratio 1.14; 95% confidence interval 1.06-1.23; P = 0.001). The association was generally consistent across prespecified subgroups and sensitivity analyses. However, only 52 trials (13.8%) were assessed as having a low risk of bias, and few published pattern-based trials reported statistically nonsignificant primary outcomes. Publication bias, selective outcome reporting, residual confounding, and differences in research and reporting practices may have influenced the findings. This trial-level association does not establish that pattern-based selection improves treatment efficacy. The research supports further evaluation in prospectively registered, methodologically rigorous trials with standardized pattern assessment and transparent reporting.

Source:
Journal reference:

Zhijun Bu, Meirong Song, Chen Chen, Xinyi Shi, Xuefeng Wang, Yao Li, Jinchen Chong, Yijia Zhu, Feng Jiang, Yugen Chen, Association between the use of traditional Chinese medicine patterns as an inclusion criterion and statistical significance in primary outcomes of randomized placebo-controlled trials of Chinese herbal formulas, Acta Pharmaceutica Sinica B, Volume 16, Issue 10, 2026, Pages 6664-6675, ISSN 2211-3835, https://doi.org/10.1016/j.apsb.2026.07.033

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gene therapy and special goggles help some blind adults detect objects again